Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Kavitha GovarthananDepartment of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Raja Sundari Meenakshi SundaramDepartment of Regenerative Medicine and Research, Government Stanley Hospital, Chennai 600001, Tamil Nadu, India.
Arthi Sunil RichardDepartment of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Siva Chander ChabathulaDepartment of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Secunda RupertDepartment of Regenerative Medicine and Research, Government Stanley Hospital, Chennai 600001, Tamil Nadu, India.
Jeswanth SathyanesanDepartment of Regenerative Medicine and Research, Government Stanley Hospital, Chennai 600001, Tamil Nadu, India.
Rama Shanker VermaDepartment of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Naveen JeyaramanDepartment of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India.ORCID 0000-0002-4362-3326
Madhan JeyaramanDepartment of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India.ORCID 0000-0002-9045-9493
Ramya Lakshmi RajendranBK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0001-6987-0854
Prakash GangadaranBK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-0658-4604
Byeong-Cheol AhnBK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Sciences, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0001-7700-3929
Funding
National Research Foundation of Korea NRF-2022R1I1A1A01068652
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Inhibition of GSK-3β Restores Differentiation Potential of Late-Passage Mesenchymal Stem Cells. · full record | OpenQuestion